Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City

por Ziff, Jacob, Vu, Trang, Dvir, Danielle, Riazi, Farah, Toribio, Wilma, Oster, Scott, Sigel, Keith, Weiss, Jeffrey
Publicado 2021

Community Case Study of Naloxone Distribution by Hospital-Based Harm Reduction Program for People Who Use Drugs in New York City

por Riazi, Farah, Toribio, Wilma, Irani, Emaun, Hughes, Terence M., Huxley-Reicher, Zina, McBratney, Elisa, Vu, Trang, Sigel, Keith, Weiss, Jeffrey J.
Publicado 2021

Increasing Access to Hepatitis C Virus Medications: A Program Model Using Patient Navigators and Specialty Pharmacy to Obtain Prior Authorization Approval

por Vu, Trang M., Toribio, Wilma, Riazi, Farah, Ciprian, Genesis, Gibbs, Nathalia, Giardina, Martha, Camacho, Jocelyn A., Parrella, Korin, Cambe, Joy, Amory, Catherine, Chasan, Rachel, Sigel, Keith M., Weiss, Jeffrey J.
Publicado 2018